Literature DB >> 1015491

Hemoccult detection of fecal occult blood quantitated by radioassay.

J R Stroehlein, V F Fairbanks, D B McGill, V L Go.   

Abstract

Results from the quaiac slide or Hemoccult (HO) test for fecal occult blood were compared with quantitative determinations of gastrointestinal loss after intravenous administration of 51Cr-labeled red cells. Subjects were 80 consecutive patients, without dietary restriction, who were referred because of clinical suspicion of gastrointestinal blood loss or complex anemia. A total of 555 stool specimens analyzed for 51Cr loss were graded negative, trace, or positive by the HO method. Of 338 specimens containing 0-2 ml/day by isotope assay, 7.4% were positive to the HO qualitative test. Loss of at least 10 ml/day in 51Cr equivalent was necessary to assure that the majority of HO reactions would be positive. Of specimens containing more than 30 ml/day, 93% were positive. The ratio of 51Cr-labeled red cell equivalents to stool volume and the percentage of positive HO reactions increased together. When this ratio exceeded 10%, two thirds of the HO responses were positive.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1015491     DOI: 10.1007/BF01072074

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  16 in total

1.  What do we gain from the sixth stool guaiac?

Authors:  D Neuhauser; A M Lewicki
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

2.  ASSESSMENT OF ROUTINE TESTS FOR OCCULT BLOOD IN FAECES.

Authors:  G ROSS; C H GRAY
Journal:  Br Med J       Date:  1964-05-23

3.  Detection of cancer and adenomas of the colon. The diagnostic value of fecal blood tests.

Authors:  A B CAMERON; H E KNOERNSCHILD; R M ZOLLINGER
Journal:  Am J Surg       Date:  1961-01       Impact factor: 2.565

4.  Fecal blood loss produced by oral and intravenous administration of various salicylates.

Authors:  M I GROSSMAN; K K MATSUMOTO; R J LICHTER
Journal:  Gastroenterology       Date:  1961-03       Impact factor: 22.682

5.  Quantitative determination of gastrointestinal bleeding using Cr51-labeled red blood cells.

Authors:  G IZAK; Y STEIN; A KARSHAI
Journal:  Am J Dig Dis       Date:  1960-01

6.  Measurement of Red-cell Loss from Gastro-intestinal Tract, using Radioactive Chromium.

Authors:  N C Jones
Journal:  Br Med J       Date:  1958-03-01

7.  The guaiac test-correlation with clinical findings.

Authors:  R N BARNETT
Journal:  Gastroenterology       Date:  1952-08       Impact factor: 22.682

8.  Clinical evaluation of various tests for occult blood in the feces.

Authors:  S O HOERR; W R BLISS; J KAUFFMAN
Journal:  J Am Med Assoc       Date:  1949-12-24

9.  Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions.

Authors:  J D Ostrow; C A Mulvaney; J R Hansell; R S Rhodes
Journal:  Am J Dig Dis       Date:  1973-11

10.  Mass screening for colorectal cancer.

Authors:  J B Hastings
Journal:  Am J Surg       Date:  1974-02       Impact factor: 2.565

View more
  18 in total

1.  Fecal occult blood testing.

Authors:  S J Winawer
Journal:  Am J Dig Dis       Date:  1976-10

2.  Is it worthwhile to perform capsule endoscopy for asymptomatic patients with positive immunochemical faecal occult blood test?

Authors:  Hideyuki Chiba; Masau Sekiguchi; Takafumi Ito; Yosuke Tsuji; Ken Ohata; Akiko Ohno; Shotaro Umezawa; Suguru Takeuchi; Kantaro Hisatomi; Takuma Teratani; Nobuyuki Matsuhashi; Hiroki Endo; Masahiko Inamori; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2011-06-25       Impact factor: 3.199

3.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

4.  Comparative studies on the "in vivo"-sensitivity of four commercial pseudoperoxidase-based faecal occult blood tests in relation to actual blood losses as calculated from measured whole body-59Fe-elimination rates.

Authors:  H C Heinrich; F Icagić
Journal:  Klin Wochenschr       Date:  1980-12-01

5.  Hemocult screening.

Authors:  R Gnauck
Journal:  Am J Dig Dis       Date:  1978-06

Review 6.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects.

Authors:  L Bertario; P Spinelli; L Gennari; P Sala; P Pizzetti; A Severini; G Cozzi; M Bellomi; F Berrino
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

8.  Immunological determination of faecal haemoglobin concentrations in dogs.

Authors:  T Jinbo; M Shimizu; S Hayashi; T Shida; T Sakamoto; S Kitao; S Yamamoto
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

9.  Antiprostaglandin synthetase activity of nonsteroidal anti-inflammatory drugs and gastrointestinal micro-bleeding: a comparison of flurbiprofen with benoxaprofen.

Authors:  A C Yeung Laiwah; T E Hilditch; P W Horton; J A Hunter
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

Review 10.  Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective.

Authors:  Amy Zhu; Marc Kaneshiro; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.